Subathra Ramamoorthy, Veranova, on when to escalate to structural elucidation and pair orthogonal techniques when characterizing an impurity.
News|Articles|May 2, 2014
- Pharmaceutical Technology-05-02-2014
- Volume 38
- Issue 5
Microscope Enables High-Resolution Materials Analysis
Microscope Enables High-Resolution Materials Analysis
The Thermo Scientific DXRxi Raman imaging microscope is designed to quickly reveal molecular structure, chemical composition, and sample morphology. The microscope can provide new insights, identify defects, and confirm product quality. By employing the new OMNIC xi image-centric software interface, users can quickly profile materials through chemical images. In addition, the DXRxi microscope can analyze large areas, providing microscopic detail in seconds.
Articles in this issue
over 12 years ago
Extractables and Leachables Testingover 12 years ago
Mass Spectrometer Enhances Performance in Protein Analysisover 12 years ago
Data Integrity in the Analytical Laboratoryover 12 years ago
Q&A with Tony Mitchell, Pharma Tech Industriesover 12 years ago
Linking Drug Shortages and Quality Metricsover 12 years ago
EU Steps Up Inspection Effortsover 12 years ago
Aggregation System Improves Analysis of Sub-Visible Particlesover 12 years ago
Boosting New Antibiotic Drug Development in Europeover 12 years ago
Freeze Drying Protein FormulationsRelated to this article
Nitin Kumar Swarnakar, PhD, global application lab manager at BASF, talks about spray drying for drying amorphous solid dispersions and Raman spectroscopy’s role as a quantitative analytical tool.
Nitin Kumar Swarnakar, PhD, global application lab manager at BASF in Tarrytown, spoke with PharmTech at AAPS PharmSci 360 about formulation and characterization challenges for amorphous solid dispersions.
FDA draft guidance on individualized genome editing lets BLAs add patient-specific variants without new trials, shifting evidence to CMC assay data.
Vibha Jawa, PhD, chief scientific officer at EpiVax, explains why the need for animal studies varies by modality and what it takes for organ-on-chip and other human-relevant models to replace these studies in IND-enabling toxicology work.
Trending on Pharmaceutical Technology
1
AAPS PharmSci 360 2026: IND-Enabling Studies vs Animal Data
2
USP 1074 Revises Excipient Safety: AAPS PharmSci 360 2026
3
AI Formulation: Regulators Want Data
4
From URS to Acceptance Evidence: Defining and Testing Interfaces in Pen Injector Assembly
5